These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1601359)

  • 1. [Increased expression of growth factors following angioplasty. Restenosis by stimulation of vascular smooth muscle cells].
    Bauriedel G
    Fortschr Med; 1992 Apr; 110(11):196. PubMed ID: 1601359
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recurrent stenosis following coronary angioplasty. Clinical, cell biological and molecular aspects].
    Hombach V; Waltenberger J; Voisard R; Höher M
    Z Kardiol; 1995 Jan; 84(1):5-21. PubMed ID: 7863714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coronary circulation-derived plasma in patients with vascular restenosis stimulates the growth of coronary artery smooth muscle cells in culture].
    Okamoto Y; Uemura S; Yamamoto H; Dohi K; Nakano H
    Rinsho Byori; 1997 Oct; 45(10):1008-12. PubMed ID: 9369081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Restenosis after coronary angioplasty. Contribution of experimental models].
    Bauters C; Hamon M; Van Belle E; Dupuis B; Lablanche JM; Bertrand ME
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():47-56. PubMed ID: 8215780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiology of restenosis following percutaneous transluminal coronary angioplasty].
    Holm AM; Haunsø S; Hansen PR
    Ugeskr Laeger; 1998 Feb; 160(9):1302-6. PubMed ID: 9495077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Restenosis after coronary angioplasty: its pathogenesis and prevention].
    Marzocchi A; Marrozzini C; Piovaccari G; Fattori R; Castriota F; D'Anniballe G; Branzi A; Magnani B
    Cardiologia; 1991 Dec; 36(12 Suppl 1):309-20. PubMed ID: 1841786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiology and pathobiochemistry of restenosis].
    Höfling B; Gonschior P; Nikol S; Bauriedel G; Welsch U; Nerlich A
    Z Kardiol; 1994 May; 83(5):313-8. PubMed ID: 8053238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The paradigm of restenosis following percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Eur Heart J; 1993 Nov; 14 Suppl I():187-92. PubMed ID: 8293774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Restenosis after angioplasty. Clinical significance, pathobiology, future developments for suppression of recurrent stenoses].
    Höfling B; Gonschior P; Esin S; Nikol S
    Internist (Berl); 1997 Jan; 38(1):31-43. PubMed ID: 9119657
    [No Abstract]   [Full Text] [Related]  

  • 10. [Restenosis after percutaneous transluminal angioplasty: I. Etiology and clinical significance].
    Alfke H; Böger RH; Bode-Böger SM
    Vasa; 1996; 25(1):13-20. PubMed ID: 8851261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factors and vascular smooth muscle cell growth responses.
    Delafontaine P
    Eur Heart J; 1998 Jul; 19 Suppl G():G18-22. PubMed ID: 9717051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathological mechanisms of restenosis after angioplasty. Cell and molecular biology findings--possible new therapeutic approaches].
    Bauriedel G
    Fortschr Med; 1994 Aug; 112(24):322-3. PubMed ID: 7959499
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biological determinants and prevention of coronary restenosis after angioplasty].
    Chen BR; Zhu LY; Wang LH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Oct; 21(5):312-3. PubMed ID: 8200317
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of smooth muscle cell proliferation and its possible role in preventing restenosis post-angioplasty.
    Nikol S; Höfling B
    Wien Klin Wochenschr; 1995; 107(13):379-89. PubMed ID: 7638968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gene therapy for the treatment of restenosis after coronary angioplasty].
    Rapacciuolo A; Indolfi C; Di Lorenzo E; Esposito G; Stabile E; Stingone AM; Avvedimento EV; Condorelli M; Chiariello M
    Cardiologia; 1994 Dec; 39(12):843-7. PubMed ID: 7781002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and prevention of restenosis: from experimental models to clinical practice.
    Bauters C; Meurice T; Hamon M; McFadden E; Lablanche JM; Bertrand ME
    Cardiovasc Res; 1996 Jun; 31(6):835-46. PubMed ID: 8759238
    [No Abstract]   [Full Text] [Related]  

  • 17. Restenosis after percutaneous transluminal coronary angioplasty: new therapeutic insights from pathogenic mechanisms.
    Berk BC; Harris K
    Adv Intern Med; 1995; 40():445-501. PubMed ID: 7747655
    [No Abstract]   [Full Text] [Related]  

  • 18. Deposition of PG-M/versican is a major cause of human coronary restenosis after percutaneous transluminal coronary angioplasty.
    Matsuura R; Isaka N; Imanaka-Yoshida K; Yoshida T; Sakakura T; Nakano T
    J Pathol; 1996 Nov; 180(3):311-6. PubMed ID: 8958811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smooth muscle cell diversity and the extracellular matrix in a rat model of restenosis.
    Majesky MW; Dong XR; Topouzis S
    P R Health Sci J; 1996 Sep; 15(3):187-91. PubMed ID: 8994283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular smooth muscle cells in coronary heart disease].
    Tsukamoto T; Matsui T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):100-4. PubMed ID: 12436513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.